Potential peptides in atherosclerosis therapy.
Marleau. Sylvie S; Mellal. Katia K; Huynh. David N DN; Ong. Huy H
Key Findings
- Peptides are being investigated as novel treatments for atherosclerosis.
- They may work by improving cholesterol handling, blocking harmful receptors on immune cells, or reducing inflammation.
- The review is mostly theoretical and based on early‑stage research, not human trials.
Practical Outcomes
- There’s no clear, actionable protocol for using humanin or other peptides right now. Enthusiasts should wait for concrete clinical data before considering self‑experimentation.
Summary
The paper talks about using small protein fragments (peptides) as possible new medicines for clogged arteries, but it’s a broad review and doesn’t give any specific tips or dosages for people to try, especially not for the peptide humanin.
Abstract
Atherosclerosis is the main underlying cause of ischemic heart disease and related acute cardiovascular complications, including myocardial infarction and stroke. In view of the failure of statins to demonstrate a beneficial effect in all patients, exhaustive research efforts have unfold into different research avenues, in close relation to the increase in basic knowledge regarding lipoprotein metabolism, macrophage function and inflammatory conditions associated with atherosclerosis. This review focuses specifically on potential therapeutic peptides targeting dyslipidemia, macrophage scavenger receptors, cholesterol metabolism and anti-inflammatory cytokines as novel therapeutic avenues in atherosclerosis.
Study Information
pubmed
2014
2014-06-10T00:00:00.000Z
10.1159/000360568
8
80